Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Price, Quote, News and Overview

NASDAQ:BBH - Nasdaq - US92189F7261 - ETF - Currency: USD

162.46  -2.12 (-1.29%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 0 industry peers in the Unkown industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. BBH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year BBH was profitable.
In the past year BBH had a positive cash flow from operations.
BBH had positive earnings in each of the past 5 years.
BBH had a positive operating cash flow in each of the past 5 years.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

BBH's Return On Assets of 5.28% is in line compared to the rest of the industry. BBH outperforms 44.58% of its industry peers.
Looking at the Return On Equity, with a value of 10.77%, BBH is in line with its industry, outperforming 43.37% of the companies in the same industry.
BBH has a Return On Invested Capital (9.29%) which is comparable to the rest of the industry.
The 3 year average ROIC (9.16%) for BBH is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

BBH has a Profit Margin of 6.93%. This is comparable to the rest of the industry: BBH outperforms 46.99% of its industry peers.
BBH's Profit Margin has declined in the last couple of years.
BBH's Operating Margin of 12.44% is in line compared to the rest of the industry. BBH outperforms 50.60% of its industry peers.
In the last couple of years the Operating Margin of BBH has remained more or less at the same level.
BBH has a Gross Margin of 29.25%. This is comparable to the rest of the industry: BBH outperforms 42.17% of its industry peers.
In the last couple of years the Gross Margin of BBH has remained more or less at the same level.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, BBH has about the same amount of shares outstanding.
Compared to 5 years ago, BBH has less shares outstanding
BBH has a better debt/assets ratio than last year.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 5.59. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.59, BBH belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
BBH has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as BBH would need 2.88 years to pay back of all of its debts.
The Debt to FCF ratio of BBH (2.88) is comparable to the rest of the industry.
BBH has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
BBH has a Debt to Equity ratio of 0.40. This is in the lower half of the industry: BBH underperforms 66.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 5.59
ROIC/WACCN/A
WACCN/A
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.82 indicates that BBH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.82, BBH is not doing good in the industry: 73.49% of the companies in the same industry are doing better.
A Quick Ratio of 1.11 indicates that BBH should not have too much problems paying its short term obligations.
BBH's Quick ratio of 1.11 is on the low side compared to the rest of the industry. BBH is outperformed by 74.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BBH have decreased strongly by -19.52% in the last year.
Measured over the past 5 years, BBH shows a small growth in Earnings Per Share. The EPS has been growing by 3.63% on average per year.
BBH shows a decrease in Revenue. In the last year, the revenue decreased by -5.57%.
BBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

The Earnings Per Share is expected to grow by 11.57% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.41% on average over the next years.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 58.23, BBH can be considered very expensive at the moment.
75.90% of the companies in the same industry are cheaper than BBH, based on the Price/Earnings ratio.
BBH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.75.
With a Price/Forward Earnings ratio of 44.04, BBH can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, BBH is valued a bit more expensive than 77.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.44. BBH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 58.23
Fwd PE 44.04
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BBH is valued more expensive than 81.93% of the companies in the same industry.
BBH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. BBH is more expensive than 74.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 38.43
EV/EBITDA 21.73
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BBH does not grow enough to justify the current Price/Earnings ratio.
BBH's earnings are expected to grow with 12.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.22
PEG (5Y)16.03
EPS Next 2Y13.1%
EPS Next 3Y12.8%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.00%, BBH is a good candidate for dividend investing.
BBH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 4%

5.2 History

The dividend of BBH is nicely growing with an annual growth rate of 7.12%!
BBH has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)7.12%
Div Incr Years0
Div Non Decr Years0
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

50.00% of the earnings are spent on dividend by BBH. This is a bit on the high side, but may be sustainable.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK BIOTECH ETF

NASDAQ:BBH (3/3/2025, 8:14:04 PM)

162.46

-2.12 (-1.29%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-51.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts75.71
Price Target184.43 (13.52%)
Short Float %0%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 4%
Yearly Dividend1.3
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.39%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 58.23
Fwd PE 44.04
P/S 4.05
P/FCF 38.43
P/OCF 21.63
P/B 6.29
P/tB 8.6
EV/EBITDA 21.73
EPS(TTM)2.79
EY1.72%
EPS(NY)3.69
Fwd EY2.27%
FCF(TTM)4.23
FCFY2.6%
OCF(TTM)7.51
OCFY4.62%
SpS40.14
BVpS25.82
TBVpS18.89
PEG (NY)3.22
PEG (5Y)16.03
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 5.59
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%